Introduction:Basic information about CAS 85175-67-3|Zatebradine, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Zatebradine |
|---|
| CAS Number | 85175-67-3 | Molecular Weight | 456.57400 |
|---|
| Density | 1.115g/cm3 | Boiling Point | 612.5ºC at 760 mmHg |
|---|
| Molecular Formula | C26H36N2O5 | Melting Point | / |
|---|
| MSDS | / | Flash Point | 324.3ºC |
|---|
Names
| Name | 3-[3-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]propyl]-7,8-dimethoxy-2,5-dihydro-1H-3-benzazepin-4-one |
|---|
| Synonym | More Synonyms |
|---|
Zatebradine BiologicalActivity
| Description | Zatebradine(UL-FS49) is a potent HCN channels antagonist, which decreased the heartbeat in a reversible manner; 92% inhibition of the hHCN1-mediated current at 10 uM.IC50 value: 10 uM(92% 92% inhibition of the hHCN1) [1]Target: hHCN channel antagonistThe pharmacological properties of hHCN1-mediated currents resembled those of native hyperpolarization-activated currents (I(h)), that is, blockade by Cs(+) (99% at 5 mm), ZD 7288 (98% at 100 microm) and zatebradine (92% at 10 microm) [1]. When voltage-clamp pulse trains were applied, cilobradine induced a use-dependent blockade of If that was stronger and faster than that with zatebradine. Recovery from blockade during prolonged hyperpolarization was significantly faster with zatebradine [2]. The selective HCN blocker zatebradine reduced the activity of oriens-lacunosum moleculare interneurons in wild-type but not HCN2(-/-) mice and decreased the frequency of spontaneous inhibitory currents in postsynaptic CA1 pyramidal cells [3]. |
|---|
| Related Catalog | Signaling Pathways >>Membrane Transporter/Ion Channel >>HCN ChannelResearch Areas >>Cardiovascular Disease |
|---|
| References | [1]. Gill CH, et al. Characterization of the human HCN1 channel and its inhibition by capsazepine. Br J Pharmacol. 2004 Oct;143(3):411-21. [2]. Van Bogaert PP, et al. Use-dependent blockade of cardiac pacemaker current (If) by cilobradine and zatebradine. Eur J Pharmacol. 2003 Oct 8;478(2-3):161-71. [3]. Matt L, et al. HCN2 channels in local inhibitory interneurons constrain LTP in the hippocampal direct perforant path. Cell Mol Life Sci. 2011 Jan;68(1):125-37. |
|---|
Chemical & Physical Properties
| Density | 1.115g/cm3 |
|---|
| Boiling Point | 612.5ºC at 760 mmHg |
|---|
| Molecular Formula | C26H36N2O5 |
|---|
| Molecular Weight | 456.57400 |
|---|
| Flash Point | 324.3ºC |
|---|
| Exact Mass | 456.26200 |
|---|
| PSA | 60.47000 |
|---|
| LogP | 3.15070 |
|---|
| Index of Refraction | 1.545 |
|---|
| InChIKey | KEDQCFRVSHYKLR-UHFFFAOYSA-N |
|---|
| SMILES | COc1ccc(CCN(C)CCCN2CCc3cc(OC)c(OC)cc3CC2=O)cc1OC |
|---|
| Storage condition | 2-8℃ |
|---|
Synonyms
| Zatebradinum [INN-Latin] |
| UL-FS-49 |
| 3-[3-[(3,4-Dimethoxy phenethyl)methylamino]-propyl]-1,3,4,5-tetrahydro-7,8-dimethoxy-2H-3-benzazepin-2-one |
| Zatebradina |
| Zatebradine |
| Zatebradine [INN] |
| 7,8-dimethoxy-3-<3-<<2-(3,4-dimethoxyphenyl)ethyl>-methylamino>propyl>-1,3,4,5-tetrahydro-2H-benzazepin-2-one |
| Zatebradina [INN-Spanish] |
| Zatebradinum |
| [14C]-Zatebradine |
| 1-[7,8-dimethoxy-1,3,4,5-tetrahydro-2H-3-benzazepin-2-on-3-yl]-3-[N-methyl-N-(2-{3,4-dimethoxy-phenyl}ethyl)-amino]-propane |